http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105219881-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2015-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105219881-B |
| titleOfInvention | The kit of quantitative detection ERCC1-202 a kind of and application |
| abstract | The kit of quantitative detection ERCC1-202 a kind of and application, including ERCC1-202 upstream and downstream primer, the upstream and downstream primer of β-Actin internal reference, ERCC1-202 probe and β-Actin probe.The present invention carries out absolute quantitation to ERCC1-202 and β-Actin according to calibration curve method respectively, and then realize ERCC1-202 relative quantification, can provide reference frame for tumour patient medication by the standard plasmid of building ERCC1-202 and internal reference β-Actin gene.The present invention can not be interfered with the expression quantity of 202 hypotype mRNA of specific detection ERCC1 gene by other hypotypes, have many advantages, such as that high specificity, sensibility are high, result is stable. |
| priorityDate | 2015-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.